Renji Hospital
Clinical trials sponsored by Renji Hospital, explained in plain language.
-
New combo aims to control resistant liver cancer
Disease control TerminatedThis study tested whether adding an experimental drug (VIC-1911) to the standard drug lenvatinib could help people with liver cancer that no longer responds to lenvatinib alone. Only 5 people were enrolled before the study was stopped early. The goal was to see if the combination…
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
A tiny dose of an old drug might stop Post-Surgery brain fog in seniors
Prevention TerminatedThis trial tests whether a single low dose of droperidol, given just before the end of surgery, can prevent postoperative delirium—a state of confusion and disorientation—in adults aged 65 and older undergoing non-cardiac surgery. About 800 participants will receive either droper…
Phase: NA • Sponsor: RenJi Hospital • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC